The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 1, 2003, Pages 17-22

  Phoenix, D A ^a   Sayed, Z ^a   Hussain, S ^a   Harris, F ^a   Wainwright, M ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Escherichia coli; Phenothiazinium; Phototoxicity; Staphylococcus aureus

Indexed keywords

DYE; OXYGEN; PHENOTHIAZINE;

ARTICLE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; ILLUMINATION; LABORATORY TEST; LETHALITY; LIPOPHILICITY; NONHUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0141749454     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00173-1     Document Type: Article

References (38)

1. Livermore D.M. Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents. 16:2001;3-10.
2. Hogan D., Kolter R. Why are bacteria refractory to antimicrobials? Curr. Opin. Microbiol. 5:2002;472-477.
3. Phoenix D.A., Chatfield L.K., Hussain S., Sayed Z., Dennison S., Harris F. Antimicrobial therapy: New solutions to an old problem. J. Eur. Coll. Qual. L. 1:2003;44-61.
4. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother. 42:1998;13-28.
5. Agostinis P., Vantieghem A., Merievede W., de Witte P.A.M. Hypercin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol. 34:2002;221-241.
6. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 1:2000;212-219.
7. Schmidt-Erfurth U., Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv. Ophthalmol. 45:2002;195-214.
8. Kurwa H.A., Barlow R.J. The role of photodynamic therapy in dermatology. Clin. Exp. Dermatol. 24:1999;143-148.
9. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kesel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-905.
10. DeRosa M.C., Crutchley R.J. Photosensitised singlet oxygen and its applications. Coord. Chem. Rev. 133-134:2002;351-371.
11. Foote C.S. Definition of type I and type II photosensitised oxidation. Photochem. Photobiol. 54:1991;659.
12. Foote C.S. Future directions and applications in photodynamic therapy. SPIE Inst. Ser. 1S6:1990;115-126.
13. Girotti A.W. Photosensitised oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J. Photochem. Photobiol. B Biol. 63:2001;103-113.
14. Davies M.J., Truscott R.J.W. Photo-oxidation of proteins and its role in caractogenesis. J. Photochem. Photobiol. B Biol. 63:2001;114-125.
15. Kawanishi S., Hiraku Y., Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and ageing. Mutat. Res. 488:2001;65-76.
16. Merchat M., Bertolini G., Giacomini P., Villanueva A., Jori G. Meso-substituted cationic porphyrins as efficient photosensitizers of Gram-positive and Gram-negative bacteria. J. Photochem. Photobiol. B Biol. 32:1996;153-157.
17. Minnock A., Vernon D.I., Schofield J., Griffiths J., Parish J.H., Brown S.B. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both Gram-negative and Gram-positive bacteria. J. Photochem. Photobiol. B Biol. 32:1996;159-164.
18. Malik Z., Hanania J., Nitzan Y. Bactericidal effects of photoactivated porphyrins. An alternative approach to antimicrobial drugs. J. Photochem. Photobiol. B Biol. 5:1990;281-293.
19. Nitzan Y., Gutterman M., Malik Z., Ehrenberg B. Inactivation of Gram-negative bacteria by photosensitised porphyrins. Photochem. Photobiol. 55:1992;89-96.
20. Malik Z., Ladan H., Nitzan Y. Photodynamic activation of Gram-negative bacteria: problems and possible solutions. J. Photochem. Photobiol. B Biol. 14:1992;262-266.
21. Bertoloni G., Rossi F., Jori G., Valduga G., Ali H., van Lier J.E. Photosensitising activity of water-and-lipid soluble phthalocyanines on eukaryotic and prokaryotic microbial cells. Microbios. 71:1992;33-46.
22. Szocs K., Gabor F., Csik G., Fidy J. δ-aminolaevulinic acid-induced porphyrin synthesis and photodynamic inactivation of Escherichia coli B. J. Photobiochem. Photobiol. B Biol. 50:1999;8-17.
23. Van der Meulen F.W., Ibrahim K., Sterenborg H.J.C.M., Alphen L.V., Maikoe A., Dankert J. Photodynamic destruction of Haemophilus parainfluenzae by endogenously produced porphyrins. J. Photochem. Photobiol. B Biol. 40:1997;204-208.
24. Lasocki K., Szpakowska M., Grzybowski J., Graczyk A. Examination of antibacterial activity of the photoactivated arginine haematoporphryn derivative. Pharmacol. Res. 39:1999;181-184.
25. Wainwright M. The emerging chemistry of blood product disinfection. Chem. Soc. Rev. 31:2002;128-136.
26. Wilson M., Burns T., Pratten J. Killing of Streptococcus sanguis in biofilms using a light-activated antimicrobial agent. J. Antimicrob. Chemother. 37:1996;377-381.
27. Tuite E.M., Kelly J.K. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J. Photochem. Photobiol. B Biol. 21:1993;103-124.
28. Pooler J., Valenzo D.P. Physicochemical determinants of the sensitizing effectiveness for photooxidation of nerve membranes by fluorescein derivatives. Photochem. Photobiol. 30:1979;491-498.
29. Cincotta L., Foley J.W., Cincotta A.H. Novel red absorbing benzo[a]phenoxazinium and benzo[a]phenothiazinium photosensitizers: in vitro evaluation. Photochem. Photobiol. 46:1987;751-758.
30. Wainwright M., Phoenix D.A., Marland J., Wareing D.R.A., Bolton F.J. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol. Med. Microbiol. 19:1997;75-80.
31. Pal M.K., Ghosh T.C. Induction of metachromasia and circular dichroism in the dye 1,9-dimethyl methylene blue by S. aureus cell wall teichoic acid. Indian J. Biochem. Biophys. 27:1990;176-178.
32. Wakayama Y., Takagi M., Yano K. Photosensitized inactivation of E. coli cells in toluidine blue-light system. Photochem. Photobiol. 32:1980;601-605.
33. Wainwright M., Phoenix D.A., Gaskell M., Marshall B. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J. Antimicrob. Chemother. 44:1999;823-825.
34. Soukos N.S., Wilson M., Burns T., Speight P.M. Photodynamic effects of toluidine blue on human oral keratinocytes and fibrioplasts and Streptococcus sanguis evaluated in vitro. Laser Surg. Med. 18:1996;253-259.
35. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J. Am. Dent. Ass. 106:1983;319-323.
36. Svaasand L.O., Gomer C.J., Morinelli E. On the physical rationale of photodynamic therapy. Future directions and applications in pharmacodynamic therapy. SPIE Inst. Ser. 1S6:1990;233-248.
37. Komeric N., Wilson M., Poole S. The effect of photodynamic action on two virulence factors of Gram-negative bacteria. Photochem. Photobiol. 72:2000;676-680.
38. Szpakowska M., Reiss J., Graczyk A., Szmigielski S., Lasocki K., Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int. J. Antimicrob. Agents. 8:1997;23-27.